The Application of mRNA in Treating Cancer

Abstract

Messenger ribonucleic acid (mRNA) immunity and polypeptides, chimeric antigen receptor T cells (CAR T),
deoxyribonucleic acid (DNA) immunity. These drugs have the advantages of simple preparation, low cost, low toxicity,
and high biosafety in cancer immunotherapy. It is an up-and-coming drug candidate for tumor treatment. At present,
many enterprises have the production technology of mRNA vaccines. International pharmaceutical enterprises for
mRNA immunotherapy of cancer are in clinical research and have shown good immune effects in clinical practice.